ApprovalTrail

Approval · Notice of Compliance 3236 · 1998

DEMADEX: Notice of Compliance 3236

Issued June 10, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3236
Date
June 10, 1998
Company
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Diuretic - antihypertensive

Products in this notice

BrandDINStatus today
DEMADEX02129000Cancelled Post Market
DEMADEX02129019Cancelled Post Market
DEMADEX02129027Cancelled Post Market
DEMADEX02129035Cancelled Post Market
DEMADEX02129094Cancelled Post Market

Medicinal ingredients